Miromatrix Medical's Series B - II Round

Miromatrix Medical raised a round of funding on October 18, 2017. Investors include Wyncrest Capital.

Miromatrix Medical is developing a way to grow transplant organs in labs. The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the huma…

Articles about Miromatrix Medical's Series B - II Round: